Overview

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
Treatment of patients with chronic myelomonocytic leukemia (CMML) and thrombocytopenia.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Groupe Francophone des Myelodysplasies
Collaborators:
GlaxoSmithKline
Novartis